A Phase I Study to Evaluate The Safety and Tolerability of Tandemly-Purified Allogeneic CD34+CD90+ HSC Administered Following Conditioning with AMG 191 to Achieve Engraftment and Immune Reconstitution in Patients with SCID

  • Smith, Angela R (PI)

Project: Research project

Project Details

Description

A Phase I Study to Evaluate The Safety and Tolerability of Tandemly-Purified Allogeneic CD34+CD90+ HSC Administered Following Conditioning with AMG 191 to Achieve Engraftment and Immune Reconstitution in Patients with SCID
StatusActive
Effective start/end date5/1/204/30/25

Funding

  • JASPER THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.